Blood Cancer

Ibrance Shows Promise in Treatment of Myelofibrosis

September 17, 2021

An Ibrance-Jakafi combination shows promise in a mouse model of myelofibrosis.

Antibodies Go Missing After COVID-19 Vaccination in Some Blood Cancer Patients

September 06, 2021

Lack of antibodies from vaccination mainly affects patients with B cell cancers. Experts say antibodies are just one piece of the puzzle and that other aspects of the immune system fend off serious cases of COVID-19.

3 Important Blood Cancer Drug Approvals You Should Know About

August 13, 2021

The confirmatory trial of one of the approved drugs, Pepaxto, was halted when data suggested it was associated with a higher mortality rate.

2 Acute Lymphoblastic Leukemia Updates

August 10, 2021

NCCN adds Rylaze to guidelines soon after was approved by the FDA and a British company reports positive results for its CAR-T therapy.

3 Updates on Mantle Cell Lymphoma

July 07, 2021

New research and updated treatment guidelines add to knowledge base on this rare blood cancer.

Increasing Access to Blood Cancer Clinical Trials

July 06, 2021

The Leukemia & Lymphoma Society is providing grants to increase trial enrollment of ethnic and racial minorities.

Updates on Pediatric Leukemia Research

June 07, 2021

Researchers are making progress in identifying drugs that target certain mutations.

Positive Results for Vyxeos in Combination With Other Drugs Reported at ASCO Meeting

June 06, 2021

Phase 1b results show manageable toxicities with Venclexta and Rydapt.

3 Updates About Chronic Lymphocytic Leukemia

June 02, 2021

NCCN recommends Brukinsa for CLL/SLL even though it is FDA-approved for mantel cell lymphoma.

Joe Biden Wants to Cure Cancer. Here’s Where to Start

January 20, 2021

Deposing the ‘Emperor of All Maladies’ will take a diverse toolkit, not a single moonshot.